SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-011430
Filing Date
2013-02-25
Accepted
2013-02-25 20:23:33
Documents
1
Period of Report
2013-02-21

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c492438_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c492438_4x0.xml 4 3822
  Complete submission text file 0001209191-13-011430.txt   5453
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Issuer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 31 WEST 52ND ST. 17TH FLOOR NEW YORK NY 10019
Business Address
Mazur Marc (Reporting) CIK: 0001361226 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31564 | Film No.: 13640762